Open original FDA record ↗Recall record
- FDA identifier
- Z-0516-04
- Company in FDA record
- Cryolife Inc
- FDA classification date
- Feb 10, 2004
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The firm received additional information from the procurement agency indicating that Yeast was detected in the musculoskeletal procurement cultures for the hemi pelvis.
Source facts
- Action
- Consignee was first notified by telephone on 11/10/2003, with a follow up letter sent 12/10/2003. If the tissue had been implanted the consignee was advised to forward that information to CryoLife''s Regulatory Department-Field Assurance. If the tissue had not been implanted the consignee was advised not to implant or further distribute the tissue. They were instructed to remove the tissue from the implantable inventory and to place it into quarantine pending return to CryoLife. A self addressed, stamped postcard was included to affirm receipt of notification and to acknowledge that the tissue had been placed into quarantine.
- Initiated
- 2003-11-10
- Root cause
- Other
- Terminated
- 2004-05-06
- Distribution
- The tissue was issued to one hospital in CA.
- Recall number
- Z-0516-04
- Recall status
- Terminated
- CDRH record ID
- 30787
- FDA classified
- 2004-02-10
- Recall event number
- 27949